Published in Bone Marrow Transplant on September 22, 2014
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood (2002) 3.56
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood (2003) 3.16
Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med (1994) 1.69
Development of a prognostic model for grading chronic graft-versus-host disease. Blood (2001) 1.65
Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol (2005) 1.59
The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42
Fasciitis after allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. J Clin Rheumatol (2003) 1.40
Health-related quality of life of pediatric patients receiving allogeneic stem cell or bone marrow transplantation: results of a longitudinal, multi-center study. Bone Marrow Transplant (2006) 1.35
Non-endocrine late complications of bone marrow transplantation in childhood: part I. Br J Haematol (2002) 1.10
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood (2011) 1.05
Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol (2005) 0.99
Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am (2010) 0.94
Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children. Transplantation (2004) 0.90
Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 0.89
Pterygium inversum unguis-like changes in scleroderma. Report of four cases. Arch Dermatol (1977) 0.82
Lichen planus-like eruption and nail changes in a patient with graft-versus-host disease. Br J Dermatol (1990) 0.81
Lichenoid nail changes as sole external manifestation of graft vs. host disease. Int J Dermatol (2002) 0.81
Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation. Blood (2013) 0.79